July 30, 2021
Video
Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.
July 29, 2021
Article
The biologic can now be used as an add-on maintenance treatment for patients who have struggled with former treatment and surgeries.
July 27, 2021
Researchers in North Carolina recorded improvements in pediatric healthcare utilization partly attributed to a lack of exposure to allergens and other exacerbations.
July 25, 2021
Sidney Braman, MD, and Geoffrey Chupp, MD, discuss other novel agents currently in clinical trials for the treatment of severe asthma.
Geoffrey Chupp, MD, and Nicola Hanania, MD, MS, review the phase 2 PATHWAY trial and the phase 3 NAVIGATOR trial details for tezepelumab in patients with severe, oral corticosteroid-dependent asthma.
July 18, 2021
Nicola Hanania, MD, MS, and Sidney Braman, MD, discuss tezepelumab as an emerging biologic suitable for patients with both T2 and non-T2 driven asthma.
Geoffrey Chupp, MD, explains the key to future asthma treatment and the direction of the T2 paradigm.
July 15, 2021
The new kinoid vaccine has shown positive results in mice with human proteins, and the France-based team remain optimistic of human trials in the future.
July 14, 2021
Roughly 60% of participants in the SINUS-24 and SINUS-52 trials reported improvements in the severity of loss-of-taste.
Researchers in the UK recommend early detection and treatment of food allergy and sensitization to avoid complications in adulthood.
